Abstract
Aim: The aim of this study was to evaluate the efficacy and outcome of BAE in hemoptysis patients. Selective bronchial artery embolization (BAE) is a minimally invasive treatment method developed alternative to surgery for acute recurrent hemoptysis.Material and Methods: The data of patients who underwent BAE with hemoptysis was collected retrospectively. The etiology of hemoptysis, localization and type of lesion, embolizing agent used and postoperative complications were recorded. Lesions were classified as pathological hypervascularity, arteriovenous fistula (AVF) and extravasation.Results: A total of 17 patients were included in this study. The most common underlying cause for hemoptysis was tuberculosis (% 40). Embolizing agents used were microspheres in 13 patients, n-BCA iodized oil mixture in 2 patients, polyvinyl alcohol particles in 1 patient and vascular plug in 1 patient. In the first 30 days after the procedures, bleeding completely stopped in 94,2% of the cases. Four patients (1 on 3rd day, 3 in 15-19 months) required re-embolization. Bronchial artery embolization was performed only once in 13 patients (76.4%), twice-in three patients (17.6%) and 3 times in 1 patient (5.8%).Conclusion: We concluded that BAE is a safe, effective and minimally invasive method that can be performed repeatedly for treatment of hemoptysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
